Mabion Capacity Update October 2025: Analytical Services

Founded in 2007 and located in Central Europe, Mabion is a fully integrated CDMO specializing in the development and support of protein-based biotherapeutics, including monoclonal antibodies, vaccine antigens, and other large proteins. We offer a comprehensive end-to-end solution, covering every stage of biologic drug development—starting from early clone selection and small-scale manufacturing to process scale-up, large-scale production, and quality control. Our services also extend to sterile fill-finish, packaging and serialization, bioanalytics, and regulatory support, ensuring a seamless path from development to commercialization.

Mabion provide a full range of analytical services crucial for the development, and manufacturing of biologics. With advanced labs and and team, we support the project from early development to market launch. From method optimization and validation to drug characterization, we tailor solutions to your needs. We monitor CQAs and CPPs during process development, conduct cGMP release testing for clinical and market readiness, and perform stability studies to secure shelf life and storage conditions.